Real-world patient data on immunity and COVID-19 status of patients with MPS, Gaucher, and Pompe diseases from Turkey터키 MPS, 고셔병, 폼페병 환자의 면역 및 COVID-19 상태에 대한 실제 환자 데이터Article Published on 2022-08-012022-09-12 Journal: Archives de pédiatrie : organe officiel de la Soci [Category] MERS, 변종, 유전자 메커니즘, 진단, [키워드] abnormality Autoimmunity being Course COVID-19 COVID-19 in patient COVID-19 infection cytokine Diagnosis discharged disease dysfunction enzyme ERT evaluate Gaucher Gaucher Disease Hashimoto thyroiditis IgA level IgM immune dysfunction Immunity immunodeficiency immunological intensive care laboratory result Laboratory tests LSD LSDs Lymphocyte count Lysosomal storage disorder median age Mild symptom MPS mucopolysaccharidosis nine parameter pathway Patient patient data patients who survived Pompe. positive problem pulmonary involvement receiving reducing reported Secondary bacterial infections social contact subgroup the patient therapy Turkey type I type III [DOI] 10.1016/j.arcped.2022.05.003 PMC 바로가기 [Article Type] Article
The effects of the COVID-19 pandemic on patients with lysosomal storage disorders in IsraelResearch Published on 2021-09-082022-10-29 Journal: Orphanet Journal of Rare Diseases [Category] COVID-19, SARS, [키워드] acute respiratory syndrome change changes in cognitive complex chronic disease Compliance coronavirus COVID-19 COVID-19 pandemic described Deterioration different diseases Disease progression disorder Effect enzyme Enzyme replacement therapy ERT home quarantine In-hospital individual lockdown LSD LSDs Lysosomal storage disorder management mandatory metabolism morbidity pandemic Patient PCR positive questionnaire rare diseases receiving reported Result SARS CoV-2 Secondary objective severity Surveillance tested Therapies therapy Treatment virus infection [DOI] 10.1186/s13023-021-02007-9 PMC 바로가기 [Article Type] Research